New findings add to mounting evidence suggesting that tea consumption may lower the risk of developing prostate cancer. The findings are based on a population-based case-control study conducted in King County, Washington. The study, by Milan S. Geybels, MSc, of the Department of Epidemiology, Maastricht University, Maastricht, The Netherlands, and colleagues examined associations between PCa risk and tea and coffee consumption. The tea-related analysis focused on 863 PCa cases and 863 controls; the coffee-related analysis included 894 cases and 860 controls. Read the article.
Another mechanism discovered by which sulforaphane prevents cancer Researchers in the Linus Pauling Institute at Oregon State University have discovered yet another reason why the “sulforaphane” compound in broccoli and other cruciferous vegetables is so good for you – it provides not just one, but two ways to prevent cancer through the complex mechanism of epigenetics. Read More.
CLICK ON THE BLUE TEXT BELOW, TO GO TO OUR VIDEOS. Click here for > Part One ” Prostate Health & Nutrition “ Eileen Fauster BA RAP C.Ir CPCC RhA ARHN Holistic Cancer Therapist, Nutritionist, Acupuncturist & Allergist Eileen Fauster talks about actively strengthening your own immunity and adopting a health-promoting lifestyle by incorporating a healing-conducive nutrition plan. Click here for >Part TWO “Herbalist Morwenna Given BA MA (Oxon) BSc m.OHA BHG RH Medical Herbalist Morwenna Given discusses the treatment and control of prostate cancer with evidence-based plant medicine in a holistic context. ——————- CLICK ON THE …
Dr. Vasundara Venkateswaran M.Sc., M.Phil., Ph.D. Associate Professor Department of Surgery, University of Toronto Division of Urology, Sunnybrook Health Sciences Centre “Diet, Nutrition and Lifestyle in relation to Prostate Cancer” There is growing evidence that, apart from the preventative benefit, diet and nutrition could play an important part in managing the progression of prostate cancer. This recognition is of particular importance to the newly-diagnosed who are considering active surveillance, to advanced prostate cancer survivors because control of cancer growth is so critical, and to regular prostate cancer survivors concerned about recurrence.